For instance, Zhou et al. reported that lncRNA SPRY4-IT1 was highly connected with glioma grade and tumor size, implying that lncRNA SPRY4-IT1 had huge potential for clinical application [7]. This evidence concerns the gene SPRY4 and central nervous system cancer.